Valneva
Created in 2013
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
8,486 32,142Activities
Technologies
Entity types
Location
6 Rue Alain Bombard, 44800 Saint-Herblain, France
Saint-Herblain
France
Employees
Scale: 501-1000
Estimated: 626
SIREN
422497560Engaged corporates
22
9 5Added in Motherbase
3 years, 6 months ago
biotech Value proposition
Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya
Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions.
We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines.
Revenues from our growing commercial business help fuel the continued advancement of our vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development, which is partnered with Pfizer, as well as vaccine candidates against the Zika virus and other global public health threats.
Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the U.S. with approximately 700 employees.
vaccinesOriginal language
Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya
Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions.
We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines.
Revenues from our growing commercial business help fuel the continued advancement of our vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development, which is partnered with Pfizer, as well as vaccine candidates against the Zika virus and other global public health threats.
Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the U.S. with approximately 700 employees.
Home - Valneva
We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
https://valneva.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 24 Apr 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 29 Mar 2024 | | |
 | Aquitaine Science Transfert (SATT Aquitaine) | Other 29 Feb 2024 | | |
 Mylan Pharmaceutical, Pharmaceutical Manufacturing | Mylan Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Nov 2023 | | |
 European Parliament European Union, Political Organizations | European Parliament European Union, Political Organizations | Other 28 Jan 2023 23 Oct 2023 | | |
 Décideurs Magazine Media, Newspaper Publishing | Décideurs Magazine Media, Newspaper Publishing | Not capitalistic Not partnership Event 2 Jul 2015 | | |
 Bouygues Energies & Services Energy, Environmental Services | Bouygues Energies & Services Energy, Environmental Services | Not capitalistic Partnership Not event 20 May 2020 | | |
 Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 30 Nov 2023 | | |
 United Nations Academic Impact International development, International Affairs | United Nations Academic Impact International development, International Affairs | Not capitalistic Partnership Not event 24 Oct 2020 30 Nov 2023 | | |
 SUEZ Environment, Environmental Services | SUEZ Environment, Environmental Services | Other 7 Aug 2021 | | |